Stroke diagnostics refer to the medical tests and evaluation methods used to diagnose a stroke in patients. A stroke occurs due to disrupted blood flow to the brain, caused by blood clots or burst blood vessels in the brain. Timely and accurate diagnosis of stroke is critical to appropriately guide treatment decisions and reduce long-term disability. Some common stroke diagnostic tests include brain imaging techniques like computed tomography (CT) scans and magnetic resonance imaging (MRI), blood tests, and physical examinations to assess neurological functions. Advances in imaging technologies have enabled early detection and differentiation between hemorrhagic and ischemic strokes, helping clinicians initiate prompt stroke treatment.
Market Dynamics:
The global stroke diagnostics market is driven by the rising geriatric population which is more prone to cardiovascular diseases and strokes. According to the World Health Organization (WHO), by 2050 over 16% of the world’s population will be over the age of 65 years. Additionally, the increasing awareness about the early diagnosis and treatment of strokes, growing healthcare expenditure, and technological advancements in imaging modalities are fueling the market growth. However, the high cost of innovative diagnostic technologies, shortage of skilled professionals, and lack of awareness in low-income regions are restraining the market size. The development of advanced non-invasive methods to differentiate between hemorrhagic and ischemic strokes within minutes offer lucrative opportunities.
Key Features of the Study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook